Details for Patent: 11,666,563
✉ Email this page to a colleague
Which drugs does patent 11,666,563 protect, and when does it expire?
Patent 11,666,563 protects OMLONTI and is included in one NDA.
This patent has nine patent family members in eight countries.
Drugs Protected by US Patent 11,666,563
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION IN PATIENTS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,666,563
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3087019 | ⤷ Sign Up | |||
| China | 111526876 | ⤷ Sign Up | |||
| European Patent Office | 3733179 | ⤷ Sign Up | |||
| Japan | 7346305 | ⤷ Sign Up | |||
| Japan | WO2019131901 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
